Need professional-grade analysis? Visit stockanalysis.com
$287.35M
24.25
728
N/A
Kingworld Medicines Group Ltd (1110) trades on Hong Kong Stock Exchange in HKD. The company is classified in the Healthcare sector under the Pharmaceutical Retailers industry. The stock currently trades at HKD0.49, up 3.13% from the previous close.
Over the past year, 1110 has traded between a low of HKD0.47 and a high of HKD0.62. The stock has gained 4.6% over this period. It is currently 20.2% below its 52-week high.
Kingworld Medicines Group Ltd has a market capitalization of $287.35M, with a price-to-earnings ratio of 24.25.
Kingworld Medicines Group Limited, an investment holding company, primarily engages in the distribution and sale of branded imported pharmaceutical and healthcare products. The company offers products for relieving cough, alleviating phlegm, soothing asthma, enhancing respiratory system, aiding digestion, promoting intestinal health, activating blood circulation, relieving pain, combating flu, and other categories under the Nin Jiom Chuan Bei Pei Pa Koa, Taiko Seirogan, Kingworld Imada Red Flower Oil, Culturelle probiotics product series brands. It also manufactures and sells electrotherapeutic and physiotherapeutic devices, and general medical examination devices; and supplies pharmaceuticals, healthcare, general foodstuffs, and medical products. In addition, the company is involved in the distribution and sale of artwork; organization of art exhibitions; distribution and sale of Chinese medicine; and engages in technology transfer and property investment activities. It operates in the People's Republic of China, Japan, the United States, Canada, Hong Kong, Taiwan, Thailand, the United Kingdom, Germany, Italy, Spain, Mexico, and internationally. The company was founded in 1996 and is headquartered in Shenzhen, the People's Republic of China.
Side-by-side comparison against top Healthcare peers.